Buscar
Biomx Inc
PHGEAñadir a la lista de seguimiento
0.186USD
-0.003-1.48%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.22MCap. mercado
PérdidaP/E TTM
Más Datos de Biomx Inc Compañía
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Información de Biomx Inc
Símbolo de cotizaciónPHGE
Nombre de la empresaBiomx Inc
Fecha de salida a bolsaDec 18, 2018
Director ejecutivoSolomon (Jonathan Eitan)
Número de empleados52
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 18
Dirección22 Einstein St.
CiudadNESS-ZIONA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísIsrael
Código postal7414003
Teléfono972723942377
Sitio Webhttps://www.biomx.com/
Símbolo de cotizaciónPHGE
Fecha de salida a bolsaDec 18, 2018
Director ejecutivoSolomon (Jonathan Eitan)
Ejecutivos de Biomx Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
9.46K
+0.01%
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
5.86K
+0.02%
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
3.63K
+0.03%
Dr. Russell G. Greig, Ph.D.
Dr. Russell G. Greig, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Mr. Eddie Williams
Mr. Eddie Williams
Independent Director
Independent Director
--
--
Dr. Jesse Goodman, M.D.
Dr. Jesse Goodman, M.D.
Independent Director
Independent Director
--
--
Mr. Jonathan S. Leff
Mr. Jonathan S. Leff
Independent Director
Independent Director
--
--
Mr. Gregory Merril
Mr. Gregory Merril
Independent Director
Independent Director
--
--
Ms. Susan Blum, CPA
Ms. Susan Blum, CPA
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
9.46K
+0.01%
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
5.86K
+0.02%
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
3.63K
+0.03%
Dr. Russell G. Greig, Ph.D.
Dr. Russell G. Greig, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Mr. Eddie Williams
Mr. Eddie Williams
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Biomx Inc?
Los cinco principales accionistas de Biomx Inc son: Mr. Jonathan Eitan Solomon
¿Cuántas instituciones poseen acciones de Biomx Inc (PHGE)?
A fecha de 2026Q1, 36 instituciones poseen acciones de Biomx Inc, con un valor de mercado combinado de aproximadamente 319.22K, lo que representa el 6.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -512775.00.